People

Thomas Willnow

mdc-berlin.de

Max Delbrück Center scientist leading Molecular Cardiovascular Research, studying intracellular sorting receptors, metabolism and Alzheimer’s disease. His training includes biology/biochemistry in Munich and postdoctoral research at UT Southwestern. Capnova identifies his research as a foundation of NeuronIcon; the International Society of Nephrology’s2011 biography explicitly names him the company’s chief scientific officer. These corporate capacities are historical, not current employment at a closed company.